Clinical trials - Press Releases

Date	Title	Company
17-Jun-2020	Diaverum continues to grow its international presence by acquiring the CTN clinic in São Paulo, Brazil	Diaverum
17-Jun-2020	FDA Grants Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to Identify IDH1 and IDH2 Mutations in Low-Grade Glioma Patients	Thermo Fisher Scientific
17-Jun-2020	Gloucestershire Hospitals NHS Trust quickly responds to COVID-19 with Citrix	Gloucestershire Hospitals NHS Trust
17-Jun-2020	Celltrion to expand COVID-19 testing portfolio to include both antigen and antibody testing kits	Celltrion Healthcare
17-Jun-2020	Kancera's drug candidate KAND567 has a positive effect on mobility in a preclinical model of spinal cord injury	Kancera AB
17-Jun-2020	ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration with Regeneron	ISA Pharmaceuticals
17-Jun-2020	Regulatory approvals and programme update	ReNeuron Group plc
17-Jun-2020	Call for pharmacists to receive formal training in suicide and self-harm	The University of Huddersfield
17-Jun-2020	PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19	PTC Therapeutics, Inc
17-Jun-2020	PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19	PTC Therapeutics
15-Jun-2020	New Phase 3 Data for TREMFYA®▼ (guselkumab), a First-in-Class IL-23 p19 Subunit Inhibitor, Show Consistent, High Levels of Skin Clearance Through Four Years in Adult Patients with Moderate to Severe Plaque Psoriasis	Janssen
13-Jun-2020	Subcutaneous Formulation of DARZALEX®▼(Daratumumab) Combination Resulted in Deep and Rapid Haematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis	Janssen Pharmaceutical Companies of Johnson & Johnson
12-Jun-2020	AstraZeneca to showcase leadership in treating type-2 diabetes and cardiorenal complications at ADA 2020	AstraZeneca
12-Jun-2020	AstraZeneca presents new data across continuum of care from its broad renal portfolio at ERA-EDTA 2020 Virtual Congress	AstraZeneca
12-Jun-2020	Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage	Amolyt Pharma
12-Jun-2020	Jazz Pharmaceuticals Announces the Poster Publication of Vyxeos® Liposomal (daunorubicin and cytarabine) Long-Term Phase 3 Data for Newly Diagnosed High-Risk/Secondary Acute Myeloid Leukaemia at EHA Annual Congress	Jazz Pharmaceuticals plc
12-Jun-2020	ZZ Biotech Announces FDA Fast Track Designation for Stroke Program	ZZ Biotech, LLC
12-Jun-2020	Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual Congress Pivotal AUTO1 study in adult ALL patients enrolling	Autolus Therapeutics plc
12-Jun-2020	Zelluna Immunotherapy raises funds to fully focus on developing allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies	Zelluna Immunotherapy
12-Jun-2020	RDIF and ChemRar deliver first batch of Avifavir antiviral drug to Russian hospitals	The Russian Direct Investment Fund